Completed
Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis
NCT00619957
- Conditions
- Other Osteoporosis
- Locations
-
- Research Site Palm Desert, California, United States
- Research Site Lakewood, Colorado, United States
- Research Site Stuart, Florida, United States
- Research Site St Louis, Missouri, United States